CAL-12THomo sapiens (Human)Cancer cell line

Also known as: Centre Antoine Lacassagne-12T, CAL 12, Cal12T, CAL12T, CAL 12T, Cal.12T, Cal-12T

🤖 AI SummaryBased on 9 publications

Quick Overview

Human cancer cell line with potential for drug sensitivity studies.

Detailed Summary

CAL-12T is a human cancer cell line derived from an unspecified tissue and disease type. It is utilized in research for understanding cancer biology and drug response. The cell line has been part of studies involving genomic and transcriptomic analyses, including investigations into gene fusions, mutations, and expression profiles. These studies contribute to the identification of potential therapeutic targets and biomarkers for cancer treatment. The cell line's characteristics, such as its genetic makeup and response to various compounds, make it a valuable resource for preclinical research.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1105
SpeciesHomo sapiens (Human)
Tissue SourceLung[UBERON:UBERON_0002048]

Donor Information

Age CategoryUnknown
SexMale

Disease Information

DiseaseLung non-small cell carcinoma
LineageLung
SubtypeNon-Small Cell Lung Cancer
OncoTree CodeNSCLC

DepMap Information

Source TypeDSMZ
Source IDACH-000826_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Cys135Phe (c.404G>T)Heterozygous-PubMed=22170099, PubMed=19147553, PubMed=16142320
MutationSimpleBRAFp.Gly466Val (c.1397G>T)Unspecified-PubMed=12068308
MutationSimpleARID2p.Gly1291Glufs*4 (c.3872del) (p.Val1290fs, c.3870delG)Heterozygous-from parent cell line CAL-12T

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
13
D13S317
11
D16S539
10
D18S51
15
D19S433
14
D21S11
29,30
D2S1338
20,23
D3S1358
17
D5S818
12
D7S820
10,11
D8S1179
15
FGA
23,24
Penta D
12,13
Penta E
11,13
TH01
6
TPOX
8
vWA
16
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

Chemistry-first approach for nomination of personalized treatment in lung cancer.

Posner B.A., Minna J.D., Kim H.S., White M.A.

Cell 173:864-878.e29(2018).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.

Zhou X.-M., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.

Cell 131:1190-1203(2007).

Characterization of a new surface epitope specific for human epithelial cells defined by a monoclonal antibody and application to tumor diagnosis.

Lalanne C.-M.

Cancer Res. 47:4417-4424(1987).

Epidermal growth factor receptor expression and suramin cytotoxicity in vitro.

Milano G.

Eur. J. Cancer 26:867-871(1990).

Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.

Bizzari J.-P., Milano G.

Cancer Chemother. Pharmacol. 28:448-454(1991).